Comparison of postoperative analgesia between interscalene and supraclavicular brachial plexus block for proximal humerus fracture surgery

Comparison of postoperative analgesia between interscalene and supraclavicular brachial plexus block for proximal humerus fracture surgery - Comparison of postoperative analgesia between interscalene and supraclavicular brachial plexus block for proximal humerus fracture surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000061112

Enrollment

Registered

2026-04-06

Start date

2026-04-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

proximal humerus fracture

Interventions

The procedure is performed under total intravenous anesthesia with remimazolam and remifentanil, with the dosage adjusted to maintain a BIS score within the range of 40-60. Fentanyl 250 ug is administ

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients with an ASA-PS 1 or 2 undergoing surgery for a proximal humerus fracture

Exclusion criteria

Exclusion criteria: Patients with cardiac dysfunction, liver dysfunction, Kidney dysfunction, respiratory dysfunction, allergy to the medication used, local infection at the puncture site and difficulty communicating

Design outcomes

Primary

Measure	Time frame
Changes over time in resting NRS score	—

Secondary

Measure	Time frame
NRS score at 0, 1, 3, 6, 12, 24 hours postoperatively, frequency of use of rescue analgesics, postoperative nausea and vomiting, SpO2, postoperative ultrasound to check for pneumothorax, adverse events	—

Countries

Japan

Contacts

Public ContactYoshiaki Terao

Nagasaki Rousai Hospital Department of Anesthesiology

yoterao@nagasakih.johas.go.jp0956-49-2191

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026